Table of Contents Table of Contents
Previous Page  17 / 110 Next Page
Information
Show Menu
Previous Page 17 / 110 Next Page
Page Background

Cachexia,

Cancer,

Chronic Pain,

Epilepsy,

Glaucoma,

HIV,

AIDS,

Multiple Sclerosis,

Nausea,

ALS,

Crohn’s

,

Hepatitis C,

Anorexia,

Arthritis,

Migraine,

Parkinson’s,

Damage to the Nervous Tissue of

the Spinal Cord with Objective Neurological Indication of

Intractable Spasticity,

PTSD,

Traumatic Brain Injury,

Use of

Azidothymidine

,

Tourette Syndrome,

Lupus,

Chemotherapy or

Radiotherapy,

Reflex Sympathetic Dystrophy,

Neurofibromatosis,

Arnold-Chiari Malformation,

Hydrocephalus,

Residual Limb Pain,

Terminal Illness with a Life Expectancy Under One Year,

Hospice

Care,

Huntington’s,

Chronic Renal Failure …

If you or someone you know suffers or endures any one of

these, you have an interest in the medical marijuana industry

and recognize the importance of analytical testing.

S

takeholder Panel on Strategic Food

Analytical Methods:

Background and Fitness for Purpose

for

CANNABIS

Susan Audino, PhD

S.A. Audino & Associates, LLC

AOAC International – Dallas, TX

September 18, 2016